Evidence map›Paper›PMID 34837161›Full record

ArticleJournal of clinical immunology2022

Correction to: Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.

Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, Yun Shan Goh, Siti Naqiah Amrun, Nicholas Ang, Menaka Priyadharsani Rajapakse, Josephine Lum, Shihui Foo, Cheryl Yi-Pin Lee and 16 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Siew-Wai FongA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Nicholas Kim-Wah YeoA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Yi-Hao ChanA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Yun Shan GohA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Siti Naqiah AmrunA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Nicholas AngSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Menaka Priyadharsani RajapakseSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Josephine LumSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Shihui FooSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Cheryl Yi-Pin LeeA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Guillaume CarissimoA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Rhonda Sin-Ling CheeA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Anthony Torres-RuestaA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Matthew Zirui TayA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Zi Wei ChangA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Chek Meng PohA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Barnaby Edward YoungNational Centre for Infectious Diseases, Singapore City, Singapore.
Paul A TambyahNational Centre for Infectious Diseases, Singapore City, Singapore.
Shirin KalimuddinDepartment of Infectious Diseases, Singapore General Hospital, Singapore City, Singapore.
Yee-Sin LeoNational Centre for Infectious Diseases, Singapore City, Singapore.
David C LyeNational Centre for Infectious Diseases, Singapore City, Singapore.
Bernett LeeSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Subhra BiswasSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Shanshan Wu HowlandSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Laurent ReniaA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
Lisa F P NgA*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore. lisa_ng@IDLabs.a-star.edu.sg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34837161
PMCPMC8626280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.